Evista is a newly approved drug used for the prevention of osteoporosis in post-menopausal women. It is classified as a Selective Estrogen Receptor Modulator (SERM). This means that it produces its effects by binding to estrogen receptors thereby inducing an estrogen-like response in certain parts of the body. Evista has been shown to reduce the body's resorption of bone, and thus decrease the overall bone turnover. In addition, Evista has been shown to decrease total cholesterol and LDL cholesterol, otherwise known as "bad" cholesterol. No effects have been observed on levels of triglycerides and HDL cholesterol.
Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Evista is used for: Treating and preventing osteoporosis (bone thinning) in women past menopause. Raloxifene affects the cycle of bone formation and breakdown in the body, and reduces loss of bone tissue. Raloxifene is used to treat or prevent osteoporosis in postmenopausal women. Raloxifene is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are otherwise at risk of invasive breast cancer. Evista is prescribed to treat and prevent osteoporosis, the brittle-bone disease that strikes some women after menopause. A variety of factors promote osteoporosis. The more factors that apply to you, the greater your chances of developing the disease. These factors include: Caucasian or Asian descentSlender buildEarly menopauseSmokingDrinkingA diet low in calciumAn inactive lifestyleOsteoporosis in the family Raloxifene (ral-OX-i-feen) is used to help prevent and treat thinning of the bones (osteoporosis) only in postmenopausal women. It works like an estrogen to stop the bone loss that can develop in women after menopause, but it does not increase the bone density as much as daily 0.625 mg doses of conjugated estrogens. Raloxifene will not treat hot flashes of menopause and may cause hot flashes to occur. Also, raloxifene does not stimulate the breast or uterus as estrogen does. Raloxifene lowers the blood concentrations of total and low-density lipoprotein (LDL) cholesterol, the bad cholesterols, but it does not increase concentrations of high-density lipoprotein (HDL) cholesterol, the good cholesterol, in your blood. | 
